Context Therapeutics
CNTX
CNTX
34 hedge funds and large institutions have $114M invested in Context Therapeutics in 2024 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
36% more funds holding
Funds holding: 25 → 34 (+9)
Holders
34
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$14.9M | |
| 2 | +$14.9M | |
| 3 | +$14.9M | |
| 4 |
NI
Nextech Invest
Zurich,
Switzerland
|
+$14.9M |
| 5 |
BOCH
Blue Owl Capital Holdings
New York
|
+$10.3M |
Top Sellers
| 1 | -$1.53M | |
| 2 | -$129K | |
| 3 | -$30.9K | |
| 4 |
SSWM
Sheets Smith Wealth Management
Winston-Salem,
North Carolina
|
-$27.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$20.8K |